| [1] |
Rahib L，Smith BD，Aizenberg R，et al.Projecting cancer incidence and deaths to 2030：the unexpected burden of thyroid，liver，and pancreas cancers in the United States[J]. Cancer Res，2014，74（11）：2913-2921.
|
| [2] |
Endo A.A historical perspective on the discovery of statins[J]. Proc Jpn Acad Ser B Phys Biol Sci，2010，86（5）：484-493.
|
| [3] |
Kotamaraju S，Williams CL，Kalyanaraman B.Statin-induced breast cancer cell death：role of inducible nitric oxide and arginase-dependent pathways[J].Cancer Res，2012，67（7）：7386-7394.
|
| [4] |
Yamazaki H，Suzuki M，Aoki T，et al.Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhitors on ubiquinone levels in rat skeletal muscle and heart：relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells[J].J Atheroscler Thromb，2013，13（1）：295-307.
|
| [5] |
Kah J，Wustenberg A，Keller AD，et al.Selective induction of apoptosis by HMG-GOA reductase inhibitors in hepatoma cells and dependence on p53 expression[J].Oncology，2012，28（3）：1077-1083.
|
| [6] |
Porfire A，Tomuta I，Muntean D，et al.Optimizing long-circulating liposomes for delivery of simvastatin to colon26 carcinoma cells[J].J Liposome Res，2014，25（4）：261-269.
|
| [7] |
Yu X，Pan Y，Ma H，et al.Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells[J].Oncol Res，2013，20（8）：351-357.
|
| [8] |
Spampanato C，Sarnataro M，Giordano E，et al.Simvastatin inhib-its cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of Bcl-2 gene expression[J].Int J Oncol，2012，40（4）：935-941.
|
| [9] |
Jemal A，Siegel R，Xu J，et al.Cancer statistics，2010[J].CA Cancer J Clin，2010，60（5）：227-300.
|
| [10] |
Heberland J，Bertz J，Wolf U，et al.German cancer statistics 2004[J].BMC Cancer，2010，10：52.
|
| [11] |
Li D，Xie K，Wolff R，et al.Pancreatic cancer[J].Lancet，2004，363（9414）：1049-1057.
|
| [12] |
Rosell R，Carc ereny E，Gervais R，et al.Erlotinib versus standard chemotherapy as first-line treatment for European patie nts with advanced EGFR mutation-positive non-small-cell lung caner（EURTAC）：a multicenter，open-label，randomized phase 3 trial[J].Lancet Oncol，2012，13（3）：239-246.
|
| [14] |
Siegel RL，Miller KD，Jemal A.Cancer statistics[J].CA Cancer J Clin，2015，65（1）：5-29.
|
| [13] |
Zhou C，Wu YL，Chen G，et al.Erlotinib versus chemotherapy as first-line treatment for pantients with advanced EGFR mutation-positive non-small-cell lung caner（OPTIMAL，CTONG-0802）：a multicentre，open-label，randomized，phase 3 study[J].Lancet Oncol，2011，12（8）：735-742.
|
| [15] |
He Z，Mangala LS，Theriot CA，et al.Cell killling and radio-sensitizing effects of at orvastatin in PC-3prostate cancer cells[J].J Radiat Res，2012，53（2）：225-233.
|
| [16] |
Martirosyan A，Clendening JW，Goard CA，et al.Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin：potential therapeutic relevance[J].BMC Cancer，2010，10：103.
|
